WisdomTree India Earnings Fund (EPI) has released an update.
ESSA Pharma Inc., a clinical stage pharmaceutical company, has successfully concluded its Annual General Meeting of Shareholders, re-electing all ten board members with high approval rates and approving key company proposals. These proposals include the re-appointment of their auditors, an increase in shares for the incentive plan, and, on an advisory level, the executive officers’ compensation. This reflects strong shareholder confidence in the current leadership and the company’s strategic initiatives.
For further insights into EPI stock, check out TipRanks’ Stock Analysis page.
